Skip to content

Zydus Lifesciences gets USFDA nod for thyroid hormone deficiency drug

The company#39;s US-based unit has received tentative approval from the US Food and Drug Administration (USFDA) to market the medication, the drug firm said in a regulatory filing.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish